Miyauchi, Akimitsu
Hamaya, Etsuro
Yang, Wenjing
Nishi, Kiyoshi
Libanati, Cesar
Tolman, Cae
Shimauchi, Junichiro
Funding for this research was provided by:
Amgen K.K.
Article History
Received: 30 June 2020
Accepted: 20 August 2020
First Online: 15 October 2020
Compliance with ethical standards
:
: A Miyauchi received consulting fees from Amgen, Astellas BioPharma K.K., and Teijin Pharma. E Hamaya, K Nishi and J Shimauchi are employees of Amgen K.K., Japan and E Hamaya reports holding stock in Amgen Inc. W Yang is an employee of Amgen Inc., USA. C Libanati is an employee of UCB Pharma, Belgium, and reports holding stock in UCB Pharma. C Tolman is an employee of Amgen and holds stock in Amgen.